Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. regulatory panel backs approval for Merck C. difficile drug
U.S. regulatory panel backs approval for Merck C. difficile drug
U.S. regulatory panel backs approval for Merck C. difficile drug
Submitted by
admin
on June 9, 2016 - 9:57pm
Source:
Yahoo/Reuters
News Tags:
FDA
Merck
C. difficile
advisory panels
bezlotoxumab
Headline:
U.S. regulatory panel backs approval for Merck C. difficile drug
Do Not Allow Advertisers to Use My Personal information
